Anbio Biotechnology (NASDAQ:NNNN) Trading 8.6% Higher – Here’s Why

Anbio Biotechnology (NASDAQ:NNNN) was up 8.6% during trading on Friday . The company traded as high as $30.49 and last traded at $29.92. Approximately 24,754 shares traded hands during mid-day trading, a decline of 62% from the average daily volume of 64,592 shares. The stock had previously closed at $27.55.

Analyst Ratings Changes

Separately, Weiss Ratings upgraded shares of Anbio Biotechnology from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Monday, February 9th. One research analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock has an average rating of “Hold”.

Anbio Biotechnology Stock Performance

Anbio Biotechnology (NASDAQ:NNNN) last announced its quarterly earnings data on Tuesday, December 30th. The company reported $0.04 EPS for the quarter. The company had revenue of $2.29 million during the quarter.

About Anbio Biotechnology

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.